[ Inside the business ]

DOCU stock analysis

DOCU · Docusign, Inc.

Services-prepackaged software. Growing 9%. Keeps 12¢ of every dollar.

Nothing unusual in its latest filings.

The future, in 7 questions

Priced in: 1.7× sales in 5 yrs. Evidence: sales +9% · 12¢ profit/$1.

01 What's priced in?1.7× sales in 5 yrs
Sales now$3.4B
Needed in 5 yrs$5.6B
Backlog$2.3B
02 Is the wave rising?Digital identity · 1.2×
'20'21'22'23'24'2551
#16 of 20 mentioning it
03 Will customers keep buying?Sales +9%, steady
No customer over 10%
Backlog $2.3B · 0.7× salesPrepaid $1.6BSales +9%, steady
04 Is it scarce?No
PricingBacklogPrepaidSell-outTight
05 More profit per sale?Keeps 12¢ per $1, rising
'22'23'24'25'2612¢
Before running costs: 79% → 79%
06 Can it fund itself?Pays its own way
05 yrsself-funded
Shares +0.0%/yrDebt $0
07 What could break it?Nothing flagged

✓ All clear

From SEC filings, price and Radar. Not advice.

The record

Early signals

Growth speeding up.

Sales growth +8%, +9%, then +9% vs. a year ago.

What could go wrong

Few warning signs.

It has moved 0.9× the market. In the 2022 rate shock it fell 65% while the market fell 24%. Debt is covered by cash.

Speculative check

Self-funding.

Passes every condition: profitable, cash-generating and financially sound.

What they sell

98% Subscription and Circulation.

Subscription and Circulation 98% · Professional Services And Other 2%

Where each dollar goes

12¢ profit.

21¢ to make what it sells, 68¢ on research and overhead, 12¢ left over. Revenue $3.4B in the last 12 months.

Its market

2.0× the economy.

The government expects its industry, software publishers, to grow 4.0% a year to 2035, vs. 2.0% for the whole economy.

Market size and share

Your call.

There's no official size for its market. Enter one you trust to see its share, and slide to see what a bigger share would mean.

Life cycle

Maturity.

It earns cash, still invests, and pays back more than it borrows.

Earnings quality

Clean.

Its numbers don't resemble those of past manipulators. Cash covers 401¢ of each $1 of profit.

Competitive advantage

2 of 8 years.

Returns beat its 8.9% cost of capital in 2 of the last 8 years. Gross margin went from 73% to 79%.

Future bets

20% on research.

$659M a year on R&D. $125M on equipment and buildings.

All figures from Docusign, Inc.'s SEC filings (EDGAR) unless tagged otherwise. Educational only, not investment advice.